ACCAACATGCTGAGATCGAA
Southern blotting
Southern blot analyses of DNA samples digested with SphI or EcoRV were done according to standard protocols, using 5' external genomic probes.
Northern blotting
Northern blot analysis was performed using the NorthernMax Kit (Ambion) with 5 μg of total RNA from mouse embryo fibroblast (MEF) cells. As probes, the HindIII fragment (corresponding to exon 4 of Evi-1 mRNA) and the Hpa1 fragment (corresponding to C-terminus of Evi-1) were 32 P labeled by random priming ( Figure S4 ). After overnight hybridization, the hybridization signals were detected by autoradiography.
Western blotting
Mouse embryo fibroblast (MEF) cells were lysed in TNE buffer (Nitta et al., 2005) , were subjected to 6.5% SDS-poly-acrylamide gel electrophoresis, and were transferred to a PVDF membrane (Millipore, Bedford, MA). The blot was incubated with three different anti-Evi-1 antibodies (C50E12; Cell Signaling Technology, sc-8707-R; santa cruz biotechnology, and the antibody generated in our laboratory (Tanaka et al., 1994) ), and visualized by the enhanced chemiluminescence method (Amersham). C50E12 and our antibody recognize N-terminal portion of Evi-1 while sc-8707-R recognizes C-termius of Evi-1.
Flow cytometric analysis
To measure HSCs and progenitors, FL or BM cells were stained with CD34-FITC, Sca-1-PE, c-Kit-APC, and biotin-conjugated antibodies to lineage markers (CD3ε, CD4, CD8a, B220, Gr-1, Mac-1, and Ter119), visualized with streptavidin-PerCP. Mac-1 was excluded from the lineage mixture for staining FL HSCs. To measure myeloid progenitors, BM cells were stained with CD34-FITC, Fcγ receptor II/III-PE, c-Kit-APC, Sca-1-PE-Cy7, and lineage-biotinstreptavidin-PerCP, and analyzed as described previously (Akashi et al., 2000) . Additional staining was carried out using following antibodies: CD45.1-FITC, CD45.2-PE, CD3ε-FITC, CD4-APC, CD8a-PE, B220-PE or APC, Gr-1-FITC or APC, Ter119-PE. Antibodies were purchased from BD Biosciences.
Retroviral constructs
The cDNA of E2A/HLF was inserted into pMX-neo. The cDNA of iCre (Shimshek et al., 2002) was inserted into pGCDNsam-eGFP. To produce oncoprotein expressing retrovirus, we used following plasmids: pMXs-neo-MLL/ENL, pMXs-neo-E2A/HLF, and MSCV-cMyc-bcl2. Labeled probes were hybridized to the Mouse Genome 430 2.0 Array® (Affymetrix®), and scanned with GeneChip Scanner 3000 7G. Expression data were extracted from image files produced on Affymetrix® GeneChip Operating Software 1.0® (GCOS®). Normalization and expression value calculation were performed using DNA-Chip Analyzer (www.dchip.org) (Li and Hung Wong, 2001 ). These expression levels were attached with standard errors as measurement accuracy, which were subsequently used to compute 90% confidence intervals of fold changes in two-group comparisons. The lower confidence bounds of fold changes were conservative estimate of the real fold changes. Differentially expressed probe sets were identified as those sets whose mean signals showed more than 1.2 fold difference between GFP (vector control) and Cre-GFP transduced cells.
Microarray analysis

Gene expression analysis of individuals with AML
To elucidate the expression pattern of the putative target genes of Evi-1 in leukemic cells, we used gene expression data of 285 individuals with AML (www.ncbi.nlm.nih.gov/geo, accession number GSE1159 [NCBI GEO]) (Valk et al., 2004) . For each probe set, the geometric mean of the hybridization intensities of all samples from the patients was calculated. The level of expression of each probe set in every sample was determined relative to this geometric mean.
Correlations of the expression between possible target genes and Evi-1 (represented with 2 probes: 215851 and 221884) were calculated using Spearman's rank correlation coefficient with expression data.
Quantitative Real-time PCR
Real-time PCR was performed using the ABI PRISM 7000 Sequence Detection System (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions.
Amplification of GAPDH cDNA was used as the endogenous normalization standard.
PCR primers used for quantitative PCR.
Taqman probe: Mm00439768_m1
Supplemental Figure Legends
Figure S1
PCR genotyping using cDNA synthesized from the mRNA in wild-type (+/+), heterozygous (+/-), and homozygous (-/-) embryos.
Figure S2
Disruption of exon 4 in Evi-1 mRNA was confirmed by sequencing the amplified PCR product of homozygous (-/-) embryo.
Figure S3
The full length coding Evi-1a (3099 bp), Evi-1b (2127 bp) and Evi-1c (3663 bp) were amplified using cDNA synthesized from total RNA in wild-type (+/+) and homozygous (-/-) embryos.
Deleted forms of Evi-1 is 217 bp (the length of exon 4) shorter than wild-type controls. Expression of Evi-1 proteins in Evi-1 +/+ and Evi-1 -/-embryos. Lysates were prepared from mouse embryo fibroblast (MEF) cells from E14.5 embryos, and were analyzed by western blotting using anti-Evi-1 antibodies (the antibody generated in our Lab and sc-8707-R).
Figure S6
Wright-Giemsa-stained, cytospin preparations of corresponding fetal livers (E14.5). Evi-1 -/-fetal liver contained primitive nucleated erythrocytes, nonnucleated definitive erythrocyte, and mature myeloid elements, and morphologically indistinguishable from wild-type fetal liver. 
Figure S12
Representative FACS plots illustrating Hoechst staining of BM progenitors at day 15 of in vitro culture. Evi-1-excised progenitors exhibited a decreased frequency of S/G2/M-phase cells.
Figure S13
Representative FACS plots illustrating Annexin-V/PI staining of BM progenitors at day 15 of in vitro culture. Evi-1-excised progenitors exhibited an increased frequency of Annexin-V + cells.
Figure S14
BM progenitors derived from wild-type or Evi-1 f/f mice were transduced with GFP or Cre/GFP retrovirus, and were cultured in liquid medium containing SCF, TPO, IGF-2, FGF-1.
Representative FACS plots illustrating the frequency of GFP + cells at day3 and day13 of the culture are shown.
Figure S15
Morphological analysis of leukemic cells from moribund cMyc-bcl2 mice.
Figure S16
Schematic representation of the two step transplantation assay. BM progenitors from wild-type or Evi-1 f/f mice were transduced with cMyc-bcl2, and were transplanted into recipients.
Leukemic cells isolated from moribund primary cMyc-bcl2 mice were then transduced with GFP or Cre-GFP expressing retrovirus. Secondary transplantation was performed by injecting 1 x 10 5 sorted GFP + cells into sublethally irradiated (6.5 Gy) recipients. 
Figure S19
Schematic representation of the method to identify the common target genes of Evi-1 shared in
HSCs and leukemic cells.
Figure S20
LSK cells derived from Evi-1 f/f mice were transduced with GFP or Cre-GFP expressing retroviruses. Total RNA was prepared from sorted GFP + cells using the Qiagen RNeasy kit.
Gene expression was assayed by qPCR for the indicated targets. Data are expressed as the delta-CT between the gene of interest and the GAPDH levels expressed in the same
Cre-transduced sample, relative to the delta-CT observed in the paired control sample. Means from three independent experiments are depicted with s.d. (Gata1, Angpt1 p < 0.02).
Table S2
Genes repressed by Evi-1 in HSCs and exhibiting an opposite expression pattern to that of Evi-1 in AML samples. Two independent probes represent Evi-1: 215851 and 221884.
(fold change>1.2, Spearman-P<0.01)
